Sudip Das, Joyeeta Chowdhury, Suchibrata Das.
Bleomycin induced flagellate pigmentation and sclerodermoid change co-existent in a patient of Hodgkin’s lymphoma.
J Pak Assoc Derma Jan ;23(4):440-2.

Bleomycin is a chemotherapeutic drug known to cause a variety of cutaneous side-effects. Pigmentary changes are the commonest. We report a case of bleomycin induced flagellate pigmentation and sclerodermoid change co-existent in a patient of Hodgkin’s lymphoma.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com